Liver cancer: connections with obesity, fatty liver, and cirrhosis
A Marengo, C Rosso, E Bugianesi - Annual review of medicine, 2016 - annualreviews.org
The burden of hepatocellular carcinoma (HCC), the most common form of liver cancer, is
steadily growing because obesity, type 2 diabetes, and nonalcoholic fatty liver disease …
steadily growing because obesity, type 2 diabetes, and nonalcoholic fatty liver disease …
[HTML][HTML] Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: a systematic review and meta-analysis
EA Selvaraj, FE Mózes, ANA Jayaswal… - Journal of …, 2021 - Elsevier
Background and Aims Vibration-controlled transient elastography (VCTE), point shear wave
elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic …
elastography (pSWE), 2-dimensional shear wave elastography (2DSWE), magnetic …
[HTML][HTML] Non-alcoholic fatty liver disease and extra-hepatic cancers
C Sanna, C Rosso, M Marietti, E Bugianesi - International journal of …, 2016 - mdpi.com
Non-alcoholic fatty liver disease (NAFLD) is a leading cause of chronic liver disease but the
second cause of death among NAFLD patients are attributed to malignancies at both …
second cause of death among NAFLD patients are attributed to malignancies at both …
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
The mechanisms that drive nonalcoholic fatty liver disease (NAFLD) remain incompletely
understood. This large multicenter study characterized the transcriptional changes that occur …
understood. This large multicenter study characterized the transcriptional changes that occur …
[PDF][PDF] Altered amino acid concentrations in NAFLD: Impact of obesity and insulin resistance
Plasma concentrations of amino acids (AAs), in particular, branched chain AAs (BCAAs), are
often found increased in nonalcoholic fatty liver disease (NAFLD); however, if this is due to …
often found increased in nonalcoholic fatty liver disease (NAFLD); however, if this is due to …
Lean NAFLD: a distinct entity shaped by differential metabolic adaptation
Conclusions This study demonstrates that E. multilocularis can induce T‐cell exhaustion
through inhibitory receptor TIGIT, and that blocking this checkpoint may reverse the …
through inhibitory receptor TIGIT, and that blocking this checkpoint may reverse the …
[HTML][HTML] MBOAT7 rs641738 variant and hepatocellular carcinoma in non-cirrhotic individuals
Nonalcoholic fatty liver disease (NAFLD) represents an emerging cause of hepatocellular
carcinoma (HCC), especially in non-cirrhotic individuals. The rs641738 C> T …
carcinoma (HCC), especially in non-cirrhotic individuals. The rs641738 C> T …
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?
Objective The full phenotypic expression of non-alcoholic fatty liver disease (NAFLD) in lean
subjects is incompletely characterised. We aimed to investigate prevalence, characteristics …
subjects is incompletely characterised. We aimed to investigate prevalence, characteristics …
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease
Background & Aims Non-invasive scoring systems (NSS) are used to identify patients with
non-alcoholic fatty liver disease (NAFLD) who are at risk of advanced fibrosis, but their …
non-alcoholic fatty liver disease (NAFLD) who are at risk of advanced fibrosis, but their …
[HTML][HTML] Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual …
Background Histologically assessed liver fibrosis stage has prognostic significance in
patients with non-alcoholic fatty liver disease (NAFLD) and is accepted as a surrogate …
patients with non-alcoholic fatty liver disease (NAFLD) and is accepted as a surrogate …